Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use |
Others observations: It is added to include buprenorphine. The medicines should only be used within an established support programme. This medicine has the best evidence for effectiveness and safety. |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| Haiti. National List of Essential Medicines | 24.05. Medications for substance use disorder |
Others observations: This medication is intended to include buprenorphine. These drugs will only be used as part of a program codified support. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use |
Others observations: It is added to include buprenorphine. The medicines should only be used within an established support programme. This medicine has the best evidence for effectiveness and safety. |
| El Salvador - 2019 | Otras DROGAS QUE AFECTAN EL SISTEMA NERVIOSO | No observations |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| Haiti. National List of Essential Medicines | 24.05. Medications for substance use disorder |
Others observations: This medication is intended to include buprenorphine. These drugs will only be used as part of a program codified support. |
| List | Section | Observation |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 02.04 ANALGESICS, ANTI-INFLAMMATORY AND ANTI-PYRETIC DRUGS | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations |
| List | Section | Observation |
|---|---|---|
| Chile. Formulario Nacional de Medicamentos. 2005 | 01.05. ANALGESICOS OPIACEOS Y ANTAGONISTAS | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Cns Opiate Agonists |
Others observations: Mixture DFT |
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use |
Others observations: It is added to include buprenorphine. The medicines should only be used within an established support programme. This medicine has the best evidence for effectiveness and safety. |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| Haiti. National List of Essential Medicines | 02.02 Opioid Analgesics |
Others observations: Cancer pain management |
| Haiti. National List of Essential Medicines | 24.05. Medications for substance use disorder |
Others observations: This medication is intended to include buprenorphine. These drugs will only be used as part of a program codified support. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.5. Medicines for disorders due to psychoactive substance use |
Others observations: It is added to include buprenorphine. The medicines should only be used within an established support programme. This medicine has the best evidence for effectiveness and safety. |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| Haiti. National List of Essential Medicines | 02.02 Opioid Analgesics |
Others observations: Cancer pain management |
| Haiti. National List of Essential Medicines | 24.05. Medications for substance use disorder |
Others observations: This medication is intended to include buprenorphine. These drugs will only be used as part of a program codified support. |
| List | Section | Observation |
|---|---|---|
| Belize. National Drug Formulary | 02.02. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 01. ANALGESIA | No observations |
| List | Section | Observation |
|---|---|---|
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 17. Analgésicos narcóticos y antagonistas |
Others observations: Hidrocloruro. |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 02.04 ANALGESICS, ANTI-INFLAMMATORY AND ANTI-PYRETIC DRUGS | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 28:08 Analgesics/Antipyretics | No observations |
| Haiti. National List of Essential Medicines | 02.02 Opioid Analgesics |
Others observations: Cancer pain management |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 02.02. ANALGESICOS OPIACEOS | No observations |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| Haiti. National List of Essential Medicines | 02.02 Opioid Analgesics |
Others observations: Cancer pain management |